top of page
Profile
Join date: May 17, 2023
Posts (4)
Oct 23, 2024 ∙ 3 min
Why We Invested - Phaseshift Technologies
By Matt Fates, Partner, and Eon Mattis, Associate Discovering Next-Generation Materials is Crucial, Yet Complicated For centuries,...
32
0
Apr 18, 2023 ∙ 6 min
Distinguishing Hype from Reality, Superlatives from Optimism - Innospark's Approach to AI Investing
We see unbounded potential for AI to positively impact how we live and work. We seek opportunities where computational intelligence...
108
0
Sep 21, 2022 ∙ 4 min
Why We Invested: Dyania Health
By Matt Fates, Partner at Innospark Ventures At any given time, there are roughly 400,000 clinical trials occurring globally. In the US,...
33
0
Matt Fates
Writer
Partner
More actions
bottom of page